Mercedes
Salgado Fernández
Hospital Universitario Virgen de las Nieves
Granada, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (8)
2024
-
Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH study
Clinical and Translational Oncology
-
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study
Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2640-2651
2021
-
Controversies in the treatment of RAS wild-type metastatic colorectal cancer
Clinical and Translational Oncology, Vol. 23, Núm. 4, pp. 827-839
2020
-
Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?
International Journal of Colorectal Disease, Vol. 35, Núm. 4, pp. 739-746
2018
-
From first line to sequential treatment in the management of metastatic pancreatic cancer
Journal of Cancer, Vol. 9, Núm. 11, pp. 1978-1988
2017
-
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681
-
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
European Journal of Cancer, Vol. 82, pp. 16-24
2016
-
SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
Clinical and Translational Oncology, Vol. 18, Núm. 12, pp. 1172-1178